Roche Holding AG's Tamiflu, known generically as oseltamivir, and GlaxoSmithKline Plc's Relenza, or zanamivir, are both recommended drugs for seasonal flu and have been shown to work against viral samples of the new disease.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.